Colorcon's Opadry EZ provides superior slip and significantly reduces the probability of the tablet sticking to the throat or esophagus.
Colorcon has developed a new coating system, Opadry EZ, to address swallowing difficulties of oral solid dosage forms. Dysphagia is a common problem particularly in the geriatric population. Regulators have issued guidance on the importance of tablet coating, not just for product differentiation purposes, but also to ease swallowing so that patient safety and compliance can be improved.
According to Dr. Ali Rajabi-Siahboomi, vice-president and chief scientific officer at Colorcon, Opadry EZ provides superior slip and significantly reduces the probability of the tablet sticking to the throat or esophagus when compared with other coating formulations.
“Colorcon set out to create a coating product that satisfied both the perception and reality of easier swallowing, with a high gloss finish that adds aesthetic appeal and increased mobility for the tablet,” said Kelly Boyer, general manager, Film Coatings at Colorcon, in a press release. “Opadry EZ is a fully formulated system, simple to prepare and use. Finished tablets are easy to handle when dry, while exhibiting exceptional slip upon contact with water. Above all, this coating addresses the growing need to improve patient acceptability and compliance, by making tablets easier to swallow.”
Source: Colorcon
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.